Real-time enrollment status for this chemotherapy induced peripheral neuropathy (cipn) clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:46 AM UTC
| NCT Number | NCT06807294 |
| Recruiting Status | Recruiting |
| Condition | Chemotherapy Induced Peripheral Neuropathy (CIPN) |
| Phase | Clinical Trial |
| Target Enrollment | 21 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Dana-Farber Cancer Institute |
| Last Updated on CT.gov | January 29, 2026 (Jan 29, 2026) |
As of July 13, 2026: Clinical trial NCT06807294 is currently recruiting participants. This clinical trial study for chemotherapy induced peripheral neuropathy (cipn) is actively seeking new participants at 1 location across the United States. The study is sponsored by Dana-Farber Cancer Institute. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06807294 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06807294 was last updated Jan 29, 2026 (January 29, 2026). HelloStudys verifies this status automatically.